Funder
Fonds Wetenschappelijk Onderzoek
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Williams, J. P. et al. HIV-1 DNA predicts disease progression and post-treatment virological control. Elife 3, e03821 (2014).
2. Perreau, M., Banga, R. & Pantaleo, G. Targeted Immune Interventions for an HIV-1 Cure. Trends Mol. Med. 23, 945–961 (2017).
3. Avettand-Fènoël, V. et al. Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications. Clin. Microbiol. Rev. 29, 859–880 (2016).
4. Lambert-Niclot, S. et al. Factors Associated With Virological Failure in HIV-1–Infected Patients Receiving Darunavir/Ritonavir Monotherapy. J. Infect. Dis. 204, 1211–1216 (2011).
5. Rutsaert, S., De Spiegelaere, W., De Clercq, L. & Vandekerckhove, L. HIV DNA as a Predictive Marker for Virologic Failure of Darunavir/r Monotherapy: A Substudy of the PROTEA Trial to Define a Cut-off for Success. EACS PS6/2 (2017).
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献